Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Peter Steven St currently holds 516,626 shares of Pacira Pharmaceuticals, Inc. (PCRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter Steven St has been a net seller of PCRX stock. They have purchased $5.7M and sold $6.1M worth of shares.
Peter Steven St's most recent insider trade was on Dec 17, 2018, when they sold 46,094 shares at $5.85 per share.
Peter Steven St serves as Executive at Pacira Pharmaceuticals, Inc. (PCRX). They have executed 52 insider transactions totaling $11.7M over their tenure at the company.
Peter Steven St holds the position of Executive at Pacira Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Peter Steven St has shown a selling trading pattern, with $5.7M in total purchases and $6.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Peter Steven St was on Nov 21, 2011, when they purchased $3.0M worth of PCRX shares. This transaction involved 461,538 shares at $6.50 per share.
Peter Steven St currently owns 516,626 shares of Pacira Pharmaceuticals, Inc. (PCRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Peter Steven St's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Peter Steven St has 52 Form 4 filings on record as an insider at Pacira Pharmaceuticals, Inc..
Set alerts for Peter Steven St and 40,000+ other insiders.